The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials
Open accessThe DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Attention deficit hyperactivity disorder (ADHD) is one of the most commonly diagnosed psychiatric disorders in childhood. A wide variety of treatments have been used for the management of ADHD. We aimed to compare the efficacy and safety of pharmacological, psychological and complementary and alternative medicine interventions for the treatment of ADHD in children and adolescents. METHODS AND FINDINGS: We performed a systematic review with network meta-analyses. Randomised controlled trials (≥ 3 weeks follow-up) were identified from published and unpublished sources through searches in PubMed and the Cochrane Library (up to April 7, 2016). Interventions of interest were pharmacological (stimulants, non-stimulants, antidepressants, antipsychotics, and other unlicensed drugs), psychological (behavioural, cognitive training and neurofeedback) and complementary and alternative medicine (dietary therapy, fatty acids, amino acids, minerals, herbal therapy, homeopathy, and physical activity). The primary outcomes were efficacy (treatment response) and acceptability (all-cause discontinuation). Secondary outcomes included discontinuation due to adverse events (tolerability), as well as serious adverse events and specific adverse events. Random-effects Bayesian network meta-analyses were conducted to obtain estimates as odds ratios (ORs) with 95% credibility intervals. We analysed interventions by class and individually. 190 randomised trials (52 different interventions grouped in 32 therapeutic classes) that enrolled 26114 participants with ADHD were included in complex networks. At the class level, behavioural therapy (alone or in combination with stimulants), stimulants, and non-stimulant seemed significantly more efficacious than placebo. Behavioural therapy in combination with stimulants seemed superior to stimulants or non-stimulants. Stimulants seemed superior to behavioural therapy, cognitive training and non-stimulants. Behavioural therapy, stimulants and their combination showed the best profile of acceptability. Stimulants and non-stimulants seemed well tolerated. Among medications, methylphenidate, amphetamine, atomoxetine, guanfacine and clonidine seemed significantly more efficacious than placebo. Methylphenidate and amphetamine seemed more efficacious than atomoxetine and guanfacine. Methylphenidate and clonidine seemed better accepted than placebo and atomoxetine. Most of the efficacious pharmacological treatments were associated with harms (anorexia, weight loss and insomnia), but an increased risk of serious adverse events was not observed. There is lack of evidence for cognitive training, neurofeedback, antidepressants, antipsychotics, dietary therapy, fatty acids, and other complementary and alternative medicine. Overall findings were limited by the clinical and methodological heterogeneity, small sample sizes of trials, short-term follow-up, and the absence of high-quality evidence; consequently, results should be interpreted with caution. CONCLUSIONS: Clinical differences may exist between the pharmacological and non-pharmacological treatment used for the management of ADHD. Uncertainties about therapies and the balance between benefits, costs and potential harms should be considered before starting treatment. There is an urgent need for high-quality randomised trials of the multiple treatments for ADHD in children and adolescents. PROSPERO, number CRD42014015008.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“A systematic review by Catalá-López et al. [180] supports their efficacy in children, though evidence in adults remains less conclusive.”
From ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives (2025) · cites this paper as [180]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies have consistently demonstrated that stimulant medications are more effective than behavioral therapy or cognitive training alone in reducing symptoms [112].”
From The Impact of Social Media & Technology on Child and Adolescent Mental Health (2025) · cites this paper as [112]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Research indicates that non-stimulants are less effective than stimulant medications but can be useful for specific cases where stimulants are not suitable [112].”
From The Impact of Social Media & Technology on Child and Adolescent Mental Health (2025) · cites this paper as [112]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Atomoxetine, a selective norepinephrine reuptake inhibitor, has been found to reduce symptoms, though it typically takes longer to achieve noticeable effects compared to stimulants [112].”
From The Impact of Social Media & Technology on Child and Adolescent Mental Health (2025) · cites this paper as [112]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Two others, one combining twenty studies with over 3,000 participants, and another combining 37 studies with over 3,800 participants, found no increase in risk of all-cause treatment discontinuation in youths (Catala-Lopez et al., 2017; Schwartz and Correll, 2014).”
From The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder (2021) · cites this paper as Catala-Lopez et al., 2017
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Self-citationDermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Inference from iterative simulation using multiple sequences
Gelman, A., & Rubin, D. B. (1992) · Statistical Science · doi:10.1214/ss/1177011136 · Cited by 16,627
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
Self-citationVos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Self-citationGRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285
Hutton, B., Salanti, G., Caldwell, D. M., Chaimani, A., Schmid, C. H., Cameron, C., Ioannidis, J. P. A., Straus, S., Thorlund, K., Jansen, J. P., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2385 · Cited by 8,269
Self-citationSPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
Chan, A.-W., Tetzlaff, J. M., Altman, D. G., Laupacis, A., Gøtzsche, P. C., Krleža-Jerić, K., Hróbjartsson, A., Mann, H., Dickersin, K., Berlin, J. A., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-3-201302050-00583 · Cited by 7,363
Self-citationVos, T., Allen, C., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31678-6 · Cited by 7,253
Self-citationThe combination of estimates from different experiments
Cochran, W. G. (1954) · Biometrics · doi:10.2307/3001666 · Cited by 5,380
Polanczyk, G. V., Salum, G. A., Sugaya, L. S., Caye, A., & Rohde, L. A. (2015) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12381 · Cited by 3,990
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
The cost of dichotomising continuous variables
Altman, D. G., & Royston, P. (2006) · BMJ · doi:10.1136/bmj.332.7549.1080 · Cited by 2,688
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000251 · Cited by 2,296
Self-citationBoutron, I., Moher, D., Altman, D. G., Schulz, K. F., Ravaud, P., & for the CONSORT Group* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-4-200802190-00008 · Cited by 2,292
Self-citationSubcommittee on Attention-Deficit/Hyperactivity Disorder, S. C. O. Q. I. A. M. (2011) · Pediatrics · doi:10.1542/peds.2011-2654 · Cited by 2,185
Kassebaum, N. J., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, J., Carter, A., Casey, D. C., Charlson, F. J., Coates, M. M., Coggeshall, M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31460-x · Cited by 2,163
Self-citationPrevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis
Thomas, R., Sanders, S., Doust, J., Beller, E., & Glasziou, P. (2015) · Pediatrics · doi:10.1542/peds.2014-3482 · Cited by 1,976
Puhan, M. A., Schunemann, H. J., Murad, M. H., Li, T., Brignardello-Petersen, R., Singh, J. A., Kessels, A. G., Guyatt, G. H., & for the GRADE Working Group (2014) · BMJ · doi:10.1136/bmj.g5630 · Cited by 1,812
Pliszka, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318054e724 · Cited by 1,765
Industry sponsorship and research outcome
Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub3 · Cited by 1,697
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Increasing value and reducing waste in research design, conduct, and analysis
Ioannidis, J. P. A., Greenland, S., Hlatky, M. A., Khoury, M. J., Macleod, M. R., Moher, D., Schulz, K. F., & Tibshirani, R. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62227-8 · Cited by 1,597
Self-citationBetter Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement
Ioannidis, J. P. A., Evans, S. J. W., Gøtzsche, P. C., O'Neill, R. T., Altman, D. G., Schulz, K., Moher, D., & for the CONSORT Group* (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00009 · Cited by 1,593
Self-citationVisser, S. N., Danielson, M. L., Bitsko, R. H., Holbrook, J. R., Kogan, M. D., Ghandour, R. M., Perou, R., & Blumberg, S. J. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.09.001 · Cited by 1,263
Dias, S., Sutton, A. J., Ades, A. E., & Welton, N. J. (2013) · Medical Decision Making · doi:10.1177/0272989x12458724 · Cited by 1,207
Sonuga-Barke, E. J. S., Brandeis, D., Cortese, S., Daley, D., Ferrin, M., Holtmann, M., Stevenson, J., Danckaerts, M., van der Oord, S., Döpfner, M., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12070991 · Cited by 1,167
SWANSON, J. M., KRAEMER, H. C., HINSHAW, S. P., ARNOLD, L. E., CONNERS, C. K., ABIKOFF, H. B., CLEVENGER, W., DAVIES, M., ELLIOTT, G. R., GREENHILL, L. L., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00011 · Cited by 1,157
Attention deficit hyperactivity disorder
Thapar, A., & Cooper, M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00238-x · Cited by 1,043
Dias, S., Welton, N. J., Sutton, A. J., Caldwell, D. M., Lu, G., & Ades, A. E. (2013) · Medical Decision Making · doi:10.1177/0272989x12455847 · Cited by 728
Ioannidis, J. P. A. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.081086 · Cited by 716
Dalsgaard, S., Østergaard, S. D., Leckman, J. F., Mortensen, P. B., & Pedersen, M. G. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61684-6 · Cited by 681
Mayo-Wilson, E., Dias, S., Mavranezouli, I., Kew, K., Clark, D. M., Ades, A. E., & Pilling, S. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)70329-3 · Cited by 680
Treatment of ADHD in children with tics: A randomized controlled trial
The Tourette’s Syndrome Study Group (2002) · Neurology · doi:10.1212/wnl.58.4.527 · Cited by 504
Dias, S., Sutton, A. J., Welton, N. J., & Ades, A. E. (2013) · Medical Decision Making · doi:10.1177/0272989x13485157 · Cited by 466
ADHD Drugs and Serious Cardiovascular Events in Children and Young Adults
Cooper, W. O., Habel, L. A., Sox, C. M., Chan, K. A., Arbogast, P. G., Cheetham, T. C., Murray, K. T., Quinn, V. P., Stein, C. M., Callahan, S. T., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1110212 · Cited by 411
Jakobsen, J. C., Katakam, K. K., Schou, A., Hellmuth, S. G., Stallknecht, S. E., Leth-Møller, K., Iversen, M., Banke, M. B., Petersen, I. J., Klingenberg, S. L., et al. (2017) · BMC Psychiatry · doi:10.1186/s12888-016-1173-2 · Cited by 366
Welton, N. J., Caldwell, D. M., Adamopoulos, E., & Vedhara, K. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp014 · Cited by 362
How to Use an Article Reporting a Multiple Treatment Comparison Meta-analysis
Mills, E. J., Ioannidis, J. P. A., Thorlund, K., Schünemann, H. J., Puhan, M. A., & Guyatt, G. H. (2012) · JAMA · doi:10.1001/2012.jama.11228 · Cited by 360
Grand challenges: integrating mental health services into priority health care platforms
Patel, V., Belkin, G. S., Chockalingam, A., Cooper, J., Saxena, S., & Unützer, J. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001448 · Cited by 356
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Ramstad, E., Krogh, H. B., Nilausen, T. D., Skoog, M., Holmskov, M., Rosendal, S., Groth, C., Magnusson, F. L., Moreira-Maia, C. R., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub2 · Cited by 347
Fluid Resuscitation in Sepsis: A Systematic Review and Network Meta-analysis
Rochwerg, B., Alhazzani, W., Sindi, A., Heels-Ansdell, D., Thabane, L., Fox-Robichaud, A., Mbuagbaw, L., Szczeklik, W., Alshamsi, F., Altayyar, S., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0178 · Cited by 309
ABIKOFF, H., HECHTMAN, L., KLEIN, R. G., WEISS, G., FLEISS, K., ETCOVITCH, J., COUSINS, L., GREENFIELD, B., MARTIN, D., & POLLACK, S. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000128791.10014.ac · Cited by 278
Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review
Chan, E., Fogler, J. M., & Hammerness, P. G. (2016) · JAMA · doi:10.1001/jama.2016.5453 · Cited by 261
Attention Deficit–Hyperactivity Disorder in Children and Adolescents
Feldman, H. M., & Reiff, M. I. (2014) · New England Journal of Medicine · doi:10.1056/nejmcp1307215 · Cited by 245
Austin, P. C., & Brunner, L. J. (2004) · Statistics in Medicine · doi:10.1002/sim.1687 · Cited by 240
Mental health research priorities for Europe
Wykes, T., Haro, J. M., Belli, S. R., Obradors-Tarragó, C., Arango, C., Ayuso-Mateos, J. L., Bitter, I., Brunn, M., Chevreul, K., Demotes-Mainard, J., et al. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00332-6 · Cited by 218
Pelsser, L. M., Frankena, K., Toorman, J., Savelkoul, H. F., Dubois, A. E., Pereira, R. R., Haagen, T. A., Rommelse, N. N., & Buitelaar, J. K. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62227-1 · Cited by 215
Storebø, O. J., Krogh, H. B., Ramstad, E., Moreira-Maia, C. R., Holmskov, M., Skoog, M., Nilausen, T. D., Magnusson, F. L., Zwi, M., Gillies, D., et al. (2015) · BMJ · doi:10.1136/bmj.h5203 · Cited by 209
Complex interventions and their implications for systematic reviews: a pragmatic approach
Petticrew, M., Anderson, L., Elder, R., Grimshaw, J., Hopkins, D., Hahn, R., Krause, L., Kristjansson, E., Mercer, S., Sipe, T., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.06.004 · Cited by 206
Connor, D. F., Barkley, R. A., & Davis, H. T. (2000) · Clinical Pediatrics · doi:10.1177/000992280003900102 · Cited by 203
Seixas, M., Weiss, M., & Müller, U. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111412095 · Cited by 197
King, S., Griffin, S., Hodges, Z., Weatherly, H., Asseburg, C., Richardson, G., Golder, S., Taylor, E., Drummond, M., & Riemsma, R. (2006) · Health Technology Assessment · doi:10.3310/hta10230 · Cited by 185
Remission versus response as the goal of therapy in ADHD: A new standard for the field?
Steele, M., Jensen, P. S., & Quinn, D. M. P. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.11.006 · Cited by 174
Network meta-analysis for comparing treatment effects of multiple interventions: an introduction
Catalá-López, F., Tobías, A., Cameron, C., Moher, D., & Hutton, B. (2014) · Rheumatology International · doi:10.1007/s00296-014-2994-2 · Cited by 170
Self-citationNonpharmacological Treatments for ADHD: A Meta-Analytic Review
Hodgson, K., Hutchinson, A. D., & Denson, L. (2014) · Journal of Attention Disorders · doi:10.1177/1087054712444732 · Cited by 168
Clonidine for Attention-Deficit/Hyperactivity Disorder: I. Efficacy and Tolerability Outcomes
Palumbo, D. R., Sallee, F. R., Pelham, W. E., Bukstein, O. G., Daviss, W. B., & McDermott, M. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31815d9af7 · Cited by 147
Snell, T., Knapp, M., Healey, A., Guglani, S., Evans‐Lacko, S., Fernandez, J., Meltzer, H., & Ford, T. (2013) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12055 · Cited by 137
Renoux, C., Shin, J., Dell'Aniello, S., Fergusson, E., & Suissa, S. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13000 · Cited by 132
Medicine Goes to School: Teachers as Sickness Brokers for ADHD
Phillips, C. B. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030182 · Cited by 130
Kollins, S. H., Jain, R., Brams, M., Segal, S., Findling, R. L., Wigal, S. B., & Khayrallah, M. (2011) · Pediatrics · doi:10.1542/peds.2010-1260 · Cited by 125
Wilens, T. E., Bukstein, O. G., Brams, M. N., Cutler, A. J., Childress, A. C., Rugino, T. A., Lyne, A., Grannis, K., & Youcha, S. H. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2011.10.012 · Cited by 125
Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents
Punja, S., Shamseer, L., Hartling, L., Urichuk, L., Vandermeer, B., Nikles, J., & Vohra, S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009996.pub2 · Cited by 122
Shin, J.-Y., Roughead, E. E., Park, B.-J., & Pratt, N. L. (2016) · BMJ · doi:10.1136/bmj.i2550 · Cited by 122
Variability in ADHD Care in Community-Based Pediatrics
Epstein, J. N., Kelleher, K. J., Baum, R., Brinkman, W. B., Peugh, J., Gardner, W., Lichtenstein, P., & Langberg, J. (2014) · Pediatrics · doi:10.1542/peds.2014-1500 · Cited by 120
Attention-deficit/hyperactivity disorder: are we helping or harming?
Thomas, R., Mitchell, G. K., & Batstra, L. (2013) · BMJ · doi:10.1136/bmj.f6172 · Cited by 109
Catalá-López, F., Macías Saint-Gerons, D., González-Bermejo, D., Rosano, G. M., Davis, B. R., Ridao, M., Zaragoza, A., Montero-Corominas, D., Tobías, A., de la Fuente-Honrubia, C., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1001971 · Cited by 109
Self-citationHutton, B., Salanti, G., Chaimani, A., Caldwell, D. M., Schmid, C., Thorlund, K., Mills, E., Catalá-López, F., Turner, L., Altman, D. G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092508 · Cited by 105
Self-citationD�pfner, M., Breuer, D., Sch�rmann, S., Metternich, T. W., Rademacher, C., & Lehmkuhl, G. (2004) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-004-1011-9 · Cited by 103
PTSD in Children and Adolescents
Kay, J., Eth, S., & Burt, V. K. (2001) · Medical Entomology and Zoology · Cited by 97
Parenting Interventions for ADHD: A Systematic Literature Review and Meta-Analysis
Coates, J., Taylor, J. A., & Sayal, K. (2015) · Journal of Attention Disorders · doi:10.1177/1087054714535952 · Cited by 97
Why the Cochrane Risk of Bias Tool Should Include Funding Source as a Standard Item
Bero, L. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.ed000075 · Cited by 96
Multiple treatment comparison meta-analyses: a step forward into complexity
Mills, E., Bansback, N., Ghement, Tholund, Kelly, S., Puhan, & Wright, G. (2011) · Clinical Epidemiology · doi:10.2147/clep.s16526 · Cited by 92
Littlewood, E., Duarte, A., Hewitt, C., Knowles, S., Palmer, S., Walker, S., Andersen, P., Araya, R., Barkham, M., Bower, P., et al. (2015) · Health Technology Assessment · doi:10.3310/hta191010 · Cited by 90
Richardson, M., Moore, D. A., Gwernan-Jones, R., Thompson-Coon, J., Ukoumunne, O., Rogers, M., Whear, R., Newlove-Delgado, T. V., Logan, S., Morris, C., et al. (2015) · Health Technology Assessment · doi:10.3310/hta19450 · Cited by 89
Surveillance search techniques identified the need to update systematic reviews
Sampson, M., Shojania, K. G., McGowan, J., Daniel, R., Rader, T., Iansavitchene, A., Ji, J., Ansari, M. T., & Moher, D. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.10.003 · Cited by 86
Self-citationStuhec, M., Munda, B., Svab, V., & Locatelli, I. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.03.006 · Cited by 83
Transparency and the European Medicines Agency — Sharing of Clinical Trial Data
Bonini, S., Eichler, H.-G., Wathion, N., & Rasi, G. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1409464 · Cited by 82
Visser, S. N., Danielson, M. L., Wolraich, M. L., Fox, M. H., Grosse, S. D., Valle, L. A., Holbrook, J. R., Claussen, A. H., & Peacock, G. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6517e1 · Cited by 77
Approaches for synthesising complex mental health interventions in meta-analysis
Caldwell, D. M., & Welton, N. J. (2016) · Evidence Based Mental Health · doi:10.1136/eb-2015-102275 · Cited by 75
Efficacy of New Generation Antidepressants: Differences Seem Illusory
Del Re, A. C., Spielmans, G. I., Flückiger, C., & Wampold, B. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063509 · Cited by 72
Emergent approaches to the meta-analysis of multiple heterogeneous complex interventions
Melendez-Torres, G. J., Bonell, C., & Thomas, J. (2015) · BMC Medical Research Methodology · doi:10.1186/s12874-015-0040-z · Cited by 64
So, C., Leung, P. W. L., & Hung, S. (2008) · Behaviour Research and Therapy · doi:10.1016/j.brat.2008.06.007 · Cited by 61
Why the Cochrane Risk of Bias Tool Should not Include Funding Source as a Standard Item
Sterne, J. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.ed000076 · Cited by 60
der Oord, S. V., Prins, P. J. M., Oosterlaan, J., & Emmelkamp, P. M. G. (2006) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-006-0574-z · Cited by 57
Catalá-López, F., Hutton, B., Núñez-Beltrán, A., Mayhew, A. D., Page, M. J., Ridao, M., Tobías, A., Catalá, M. A., Tabarés-Seisdedos, R., & Moher, D. (2015) · Systematic Reviews · doi:10.1186/s13643-015-0005-7 · Cited by 51
Self-citationCarlson, G. A., Dunn, D., Kelsey, D., Ruff, D., Ball, S., Ahrbecker, L., & Allen, A. J. (2007) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/1753-2000-1-10 · Cited by 44
Childhood attention-deficit/hyperactivity disorder
Verkuijl, N., Perkins, M., & Fazel, M. (2015) · BMJ · doi:10.1136/bmj.h2168 · Cited by 42
Clyburne-Sherin, A., Thurairajah, P., Kapadia, M. Z., Sampson, M., Chan, W. W. Y., & Offringa, M. (2015) · Trials · doi:10.1186/s13063-015-0954-0 · Cited by 41
Boyle, M. H., & Jadad, A. R. (1999) · The Canadian Journal of Psychiatry · doi:10.1177/070674379904401005 · Cited by 37
ADHD in children and adolescents.
Keen, D. V., & Hadijikoumi, I. (2008) · Europe PMC (PubMed Central) · Cited by 33
Risk of Suicidal Events With Atomoxetine Compared to Stimulant Treatment: A Cohort Study
Linden, S., Bussing, R., Kubilis, P. S., Gerhard, T., Segal, R., Shuster, J. J., & Winterstein, A. G. (2016) · PEDIATRICS · doi:10.1542/peds.2015-3199 · Cited by 29
Hutton, B., Yazdi, F., Bordeleau, L. J., Morgan, S. C., Cameron, C. G., Kanji, S., Fergusson, D. A., Tricco, A. C., Straus, S. E., Skidmore, B., et al. (2015) · Systematic Reviews · doi:10.1186/s13643-015-0099-y · Cited by 27
Self-citationHutton, B., Tetzlaff, J., Yazdi, F., Thielman, J., Kanji, S., Fergusson, D. A., Bjerre, L. M., Mills, E. J., Thorlund, K., Tricco, A. C., et al. (2013) · Systematic Reviews · doi:10.1186/2046-4053-2-44 · Cited by 19
Self-citationMosseri, J., Trinquart, L., Nizard, R., & Ravaud, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146336 · Cited by 15
ADHD in Children and Adolescents
Woods, K., Danko, C. M., & Chronis-Tuscano, A. M. (2016) · Oxford University Press eBooks · doi:10.1093/acrefore/9780190236557.013.75 · Cited by 14
Catalá-López, F., Hutton, B., & Moher, D. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.11.016 · Cited by 13
Self-citationWhy are we failing young patients with ADHD?
Bowers, S. (2014) · BMJ · doi:10.1136/bmj.g6082 · Cited by 3
The realities and needs of children living with ADHD
Lancet, T. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61146-6 · Cited by 3
Cited by
Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., Newcorn, J. H., Gignac, M., Al Saud, N. M., Manor, I., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.01.022 · Cited by 1,545
“Two others, one combining twenty studies with over 3000 participants, and another combining 37 studies with over 3800 participants, found no increase in risk of all-cause treatment discontinuation in youths (Catala-Lopez et al., 2017; Schwartz and Correll, 2014).”
Cortese, S., Adamo, N., Del Giovane, C., Mohr-Jensen, C., Hayes, A. J., Carucci, S., Atkinson, L. Z., Tessari, L., Banaschewski, T., Coghill, D., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30269-4 · Cited by 1,716
Faraone, S. V. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.001 · Cited by 631
“AMP and MPH have been shown to exhibit comparable efficacy in 2 meta-analyses (Faraone and Glatt, 2010; Catala-Lopez et al., 2017), with other analyses reporting that AMP has moderately greater effects than MPH (Faraone and Buitelaar, 2010; Joseph et al., 2017; Stuhec et al., 2015).”
Neurodiversity at work: a biopsychosocial model and the impact on working adults
Doyle, N. (2020) · British Medical Bulletin · doi:10.1093/bmb/ldaa021 · Cited by 527
Kollins, S. H., DeLoss, D. J., Cañadas, E., Lutz, J., Findling, R. L., Keefe, R. S. E., Epstein, J. N., Cutler, A. J., & Faraone, S. V. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30017-0 · Cited by 385
Metadata
- Authors
- Catalá-López, F., Hutton, B., Núñez-Beltrán, A., Page, M. J., Ridao, M., Macías Saint-Gerons, D., Catalá, M. A., Tabarés-Seisdedos, R., & Moher, D.
- Affiliations
- Universitat de València (ES)
- University of Ottawa (CA)
- University of Bristol (GB)
- Corresponding author
- Catalá-López, Ferrán
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-07-12
- Volume
- 12
- Issue
- 7
- Pages
- e0180355
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5507500
- OpenAlex
- W2735057791
- Semantic Scholar
- e66b73662b208e9cf7a659046d713a96c5f5d574
- Cited by
- 396
- References
- 102
- Citations by year
- 2026: 26 · 2025: 53 · 2024: 39 · 2023: 51 · 2022: 48 · 2021: 76 · 2020: 40 · 2019: 29 · 2018: 29 · 2017: 4
- FWCI
- 4.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Monash University Research Portal (Monash University) (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Repository of Digital Objects for Teaching Research and Culture (University of Valencia) (submittedVersion, cc-by-nc)
- Funders
- Fundación Alicia Koplowitz
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Social Sciences › Psychology › Neuropsychology and Physiological Psychology › Developmental and Educational Neuropsychology
- Keywords
- attention deficit hyperactivity disorder, ADHD treatment, stimulants, non-stimulant medication, methylphenidate, amphetamine, atomoxetine, guanfacine, clonidine, behavior therapy, cognitive training, neurofeedback, complementary and alternative medicine, dietary therapy, fatty acids, herbal medicine, homeopathy, physical activity, treatment efficacy, treatment acceptability, adverse events, children and adolescents
- MeSH terms
- Adolescent, Complementary Therapies, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Behavior Therapy, Central Nervous System Depressants, Child, Female, Humans, Male, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.